Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-24-117737
Filing Date
2024-11-13
Accepted
2024-11-13 16:30:24
Documents
1
Group Members
DAVID ROSEN

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2427812d1_sc13g.htm SC 13G 77742
  Complete submission text file 0001104659-24-117737.txt   79411
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Subject) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91363 | Film No.: 241454860
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017
Business Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017 2124181881
Rubric Capital Management LP (Filed by) CIK: 0001687509 (see all company filings)

EIN.: 300934659 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G